Works matching DE "RIFAXIMIN"


Results: 162
    1
    2
    3
    4
    5
    6
    7
    8

    Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54117-6
    By:
    • Jørgensen, S. F.;
    • Macpherson, M. E.;
    • Bjørnetrø, T.;
    • Holm, K.;
    • Kummen, M.;
    • Rashidi, A.;
    • Michelsen, A. E.;
    • Lekva, T.;
    • Halvorsen, B.;
    • Trøseid, M.;
    • Mollnes, T. E.;
    • Berge, R. K.;
    • Yndestad, A.;
    • Ueland, T.;
    • Karlsen, T. H.;
    • Aukrust, P.;
    • Hov, J. R.;
    • Fevang, B.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites.

    Published in:
    Medicina (1010660X), 2022, v. 58, n. 9, p. 1276, doi. 10.3390/medicina58091276
    By:
    • Yokoyama, Keiji;
    • Fukuda, Hiromi;
    • Yamauchi, Ryo;
    • Higashi, Masashi;
    • Miyayama, Takashi;
    • Higashi, Tomotaka;
    • Uchida, Yotaro;
    • Shibata, Kumiko;
    • Tsuchiya, Naoaki;
    • Fukunaga, Atsushi;
    • Umeda, Kaoru;
    • Takata, Kazuhide;
    • Tanaka, Takashi;
    • Shakado, Satoshi;
    • Sakisaka, Shotaro;
    • Hirai, Fumihito
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    45
    46

    Issue Cover.

    Published in:
    Liver International, 2023, v. 43, n. 3, p. i, doi. 10.1111/liv.15543
    By:
    • de Wit, Koos;
    • Beuers, Ulrich;
    • Mukha, Anna;
    • Stigter, Edwin C. A.;
    • Gulersonmez, M. Can;
    • Ramos Pittol, Jose M.;
    • Middendorp, Sabine;
    • Takkenberg, R. Bart;
    • van Mil, Saskia W. C.
    Publication type:
    Article
    47
    48
    49

    Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH).

    Published in:
    Liver International, 2022, v. 42, n. 5, p. 1109, doi. 10.1111/liv.15207
    By:
    • Jiménez, César;
    • Ventura‐Cots, Meritxell;
    • Sala, Margarita;
    • Calafat, Margalida;
    • Garcia‐Retortillo, Montserrat;
    • Cirera, Isabel;
    • Cañete, Nuria;
    • Soriano, Germán;
    • Poca, María;
    • Simón‐Talero, Macarena;
    • Altamirano, José;
    • Lucey, Michael;
    • Garcia‐Tsao, Guadalupe;
    • Brown, Robert S.;
    • Schwabe, Robert F.;
    • Verna, Elizabeth C.;
    • Schnabl, Bernd;
    • Bosques‐Padilla, Francisco;
    • Mathurin, Philippe;
    • Caballería, Juan
    Publication type:
    Article
    50